Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
about
Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma.Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma.Ratio of involved/uninvolved immunoglobulin quantification by Hevylite™ assay: clinical and prognostic impact in multiple myeloma.Renal failure in multiple myeloma: a medical emergency.
P2860
Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Staging multiple myeloma patie ...... er with IgM or platelet count.
@en
Staging multiple myeloma patie ...... er with IgM or platelet count.
@nl
type
label
Staging multiple myeloma patie ...... er with IgM or platelet count.
@en
Staging multiple myeloma patie ...... er with IgM or platelet count.
@nl
prefLabel
Staging multiple myeloma patie ...... er with IgM or platelet count.
@en
Staging multiple myeloma patie ...... er with IgM or platelet count.
@nl
P50
P1476
Staging multiple myeloma patie ...... er with IgM or platelet count.
@en
P2093
Franco Dammacco
Marcella Prete
P356
10.1016/J.BCMD.2008.09.003
P577
2008-11-07T00:00:00Z